CEESAY ABRAHAM (Chief Executive Officer) sold 1.8% of their position (8.21K shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market sale worth $374.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/9/2026ACC: 0001193125-26-386436
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-8.21K
Net shares
Net seller
$374.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
8.21K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7.14K
Price / share
$45.55
Trade value
$325.31K
% of position
1.5%
9/8/2026
467.19K→460.05K
Common Stock
Direct
Shares
−1.07K
Price / share
$46.01
Trade value
$49.19K
% of position
0.2%
9/8/2026
460.05K→458.98K
Total
Net shares
−8.21K
Net value
-$374.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/8/2026 | S · Sale | −7.14K | $45.55 | $325.31K | 1.5% | 467.19K | 460.05K |
| Common Stock Direct | 9/8/2026 | S · Sale | −1.07K | $46.01 | $49.19K | 0.2% | 460.05K | 458.98K |
| Total | −8.21K | -$374.50K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned81.73K
Common Stock
IndirectShares owned20.73K
Total
102.46K indirect102.46K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 81.73K | Indirect |
| Common Stock | 20.73K | Indirect |
| Total | 102.46K | 102.46K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported